Peregrine Market Access and BeiGene
BTK Inhibitors AR Review (Market Access)
BeiGene needed to communicate to access decision makers the clinical value and head-to-head trial results for BRUKINSA, a third-to-market Bruton tyrosine kinase (BTK) inhibitor. This digital Visual Aid gave BeiGene account directors an effective tool to share key data and value messaging and differentiate BRUKINSA in a succinct, easy-to-consume manner.
Peregrine Market Access Team Members:
Michele Barcalow, Senior Vice President, Account Services
McKenna Jacobson, Account Executive
Patrick Gless, Vice President, Content Expert
Monica Kessler, Art Director
Amy Podesva, PharmD, RPh, Medical Writer
Jim Mittler, PhD, Partner, Medical Strategy and Health Economics
Eric Delnicki, Senior Vice President, Creative Director
Roger Haskins, Senior Vice President, Creative Director
Jessica Vedder, Associate Director, Resource and Project Management
Meaghan Kelly, Director, Editorial Services
BeiGene USA, Inc. Team Members:
Steve Harris, Director, Market Access Strategic Marketing
Dave James, Executive Director, Market Access Value & Strategy
Ryan O’Leary, Senior Manager, Market Access Value & Strategy
